相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Autoantibodies to estrogen receptor a interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus
Tania Colasanti et al.
ARTHRITIS AND RHEUMATISM (2012)
T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy
Cristiano Alessandri et al.
FASEB JOURNAL (2012)
Patient-acceptable Symptom State as an Outcome Measure in the Daily Care of Patients with Ankylosing Spondylitis
Carlos Rodriguez-Lozano et al.
JOURNAL OF RHEUMATOLOGY (2012)
Neurocognitive Dysfunction in Systemic Lupus Erythematosus: Association with Antiphospholipid Antibodies, Disease Activity and Chronic Damage
Fabrizio Conti et al.
PLOS ONE (2012)
Flare, Persistently Active Disease, and Serologically Active Clinically Quiescent Disease in Systemic Lupus Erythematosus: A 2-Year Follow-Up Study
Fabrizio Conti et al.
PLOS ONE (2012)
Lupus arthritis-do we have a clinically useful classification?
Elisabeth M. A. Ball et al.
RHEUMATOLOGY (2012)
Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study
F. Tubach et al.
ARTHRITIS CARE & RESEARCH (2012)
Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID)
Maxime Dougados et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Toll-like Receptors and Lupus Nephritis
Fabrizio Conti et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2011)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
M. Mosca et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Identification of Cutpoints for Acceptable Health Status and Important Improvement in Patient-Reported Outcomes, in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
Maria Knoph Kvamme et al.
JOURNAL OF RHEUMATOLOGY (2010)
Clinical and Serologic Correlations and Autoantibody Clusters in Systemic Lupus Erythematosus A Retrospective Review of 917 Patients in South China
Xuhua Tang et al.
MEDICINE (2010)
Thresholds of Patient-Reported Outcomes That Define the Patient Acceptable Symptom State in Ankylosing Spondylitis Vary Over Time and by Treatment and Patient Characteristics
Walter P. Maksymowych et al.
ARTHRITIS CARE & RESEARCH (2010)
Low incidence of flare and persistent active disease in a cohort of Italian patients with systemic lupus erythematosus: comment on the article by Nikpour et al
Fabrizio Conti et al.
ARTHRITIS CARE & RESEARCH (2010)
Frequency and Determinants of Flare and Persistently Active Disease in Systemic Lupus Erythematosus
Mandana Nikpour et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: Data from a randomized controlled trial
Maxime Dougados et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis
T. Heiberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Development and validation of a disease-specific health-related quality of life measure, the LupusQoL, for adults with systemic lupus erythematosus
Kathleen McElhone et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing-spondylitis
Walter P. Maksymowych et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Evaluation of the Patient Acceptable Symptom State in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis
Maxime Dougados et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Feeling good rather than feeling better matters more to patients
Florence Tubach et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2006)
Combined oral contraceptives in women with systemic lupus erythematosus
M Petri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations
P Margutti et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state
F Tubach et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies
F Conti et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study
R Priori et al.
LUPUS (2003)
The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus
M Mosca et al.
LUPUS (2000)